
Evommune
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -540 | -349 | -326 | |
EBITDA | -32,786 | -34,343 | -23,605 | -29,390 |
EBIT | -33,326 | -34,895 | -23,954 | -29,716 |
Net Income | -30,877 | -32,246 | -21,674 | -28,273 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,115 | -20,499 | -27,586 | -16,803 |
Cash | 47,570 | 60,034 | 48,318 | 44,063 |
Basic Shares | 36,326 | 36,135 | 33,670 | 19,775 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $13,000 | $7,000 | $5,000 |
Gross Profit | 13,000 | 5,713 | 4,000 |
EBITDA | -79,682 | -65,487 | -32,995 |
EBIT | -81,071 | -66,774 | -33,995 |
Net Income | -68,870 | -66,808 | -34,053 |
Net Change In Cash | 13,000 | 7,000 | 5,000 |
Free Cash Flow | -76,676 | -58,283 | -30,088 |
Cash | 44,063 | 16,254 | 29,024 |
Basic Shares | 6,136 | 30,077 | 30,077 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.85 |
2026-06-30 | -$0.89 |
2026-03-31 | -$0.64 |
2025-12-31 | -$1.43 |